Immune Activation Could Hold the Key to Success of Dual-Target CAR T Therapy in Glioblastoma
Dual-target CAR T Cell Therapy Delivered via Cerebrospinal Fluid Elicits Distinct Immune Responses in Recurrent Glioblastoma Recurrent glioblastoma (GBM), a ...
